In terms of anti-cancer mechanisms, metformin can directly inhibit the malignant characteristics of cancer cells through activating AMPK signaling, or indirectly prevent tumorigenesis through controlling circulating glucose and insulin levels (Linkeviciute-Ulinskiene et al., 2020). This evidence concerns the gene INS and cancer.